Now showing items 1-1 of 1

    • Use of perlecan domain V in treating amyloidogenic disease 

      Bix, Gregory J.; Wright, Sarah; Griswold-prenner, Irene (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2016-06-07)
      The application reports that perlecan domain V (DV) or the LG3 domain thereof reduces deposition and toxicity of Aβ peptide, the major component of plaques in Alzheimer's disease. Methods of using DV, LG3 and related ...